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Abstract
© 2018 Human Stem Cell Institute. All rights reserved. Cell death is an important part of normal
(physiological) and pathological histogenesis. In the past two decades, our knowledge of the
processes  of  non-programmed  and  programmed  cell  death  significantly  enriched.  The
International Nomenclature Committee on Cell Death is constantly working, it regularly updates
information on the terminology and development mechanisms recommended for this or that
type of death, but the general principle of classification of cell death has not yet been worked
out. In this review, the principle of separation according to which the mechanisms involved in
physiological  histogenesis  include  the  rooting,  the  external  pathway  of  apoptosis,  anoikis,
macroautophagy and lysosome-dependent cell death. The mechanisms involved in pathological
histogenesis include: the internal pathway of apoptosis, necroptosis, pyroptosis, netosis, mitotic
catastrophe, partanatosis, entosis, mitochondrial-driven necrosis, ferroptosis, immunogenic cell
death, necrosis and oncosis.
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